Showing results (81-90 of 106) with videos related to
Sort By:
Pageof 11
Cancers|January 11, 2022
The Increasing Prognostic and Predictive Roles of the Tumor Primary Chemosensitivity Assessed by CA-125 Elimination Rate Constant K (KELIM) in Ovarian Cancer: A Narrative ReviewAmbroise Lauby, Olivier Colomban, Pauline Corbaux, et al.Cancer Chemotherapy and Pharmacology|February 25, 2023
Clinical results of the EVESOR trial, a multiparameter phase I trial of everolimus and sorafenib combination in solid tumorsRomain Varnier, Alicja Puszkiel, Michel Tod, et al.The American Journal of Surgical Pathology|November 19, 2025
Molecular Relationship Between Ovarian Sertoli-Leydig Cell Tumors and Their Heterologous Elements: Emphasis on the Possible Prognostic Significance of TERT Pathogenic VariantsAlexis Trecourt, Clémence Scard, Françoise Descotes, et al.Targeted Oncology|August 20, 2015
Does Molecular Genotype Provide Useful Information in the Management of Radioiodine Refractory Thyroid Cancers? Results of a Retrospective StudyChristelle de la Fouchardiere, Nadia Oussaid, Olfa Derbel, et al.Annals of Intensive Care|March 5, 2022
Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patientsFrank Bidar, Sarah Hamada, Morgane Gossez, et al.Biorxiv : the Preprint Server for Biology|August 6, 2025
GFAP Degradation in TBI: Linking Novel Modified Products to Astrocyte Pathology and Patient OutcomeIna-Beate Wanner, Julia Halford, Jonathan Lopez, et al.Nature Communications|October 26, 2017
BCL-X<sub>L</sub> directly modulates RAS signalling to favour cancer cell stemnessSophie de Carné Trécesson, Frédérique Souazé, Agnès Basseville, et al.Journal for Immunotherapy of Cancer|June 18, 2026
Melanoma cell states shape spatial tumor-immune ecosystems to dictate the efficacy of anti-PD1 immunotherapyFélix K Pham, Marion Dufeu, Valentin Benboubker, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 10, 2024
Primary Vulvar and Vaginal Adenocarcinomas of Intestinal Type Are Closer To Colorectal Adenocarcinomas Than To Carcinomas of Müllerian OriginAlexis Trecourt, Isabelle Treilleux, Daniel Pissaloux, et al.Journal for Immunotherapy of Cancer|March 15, 2022
ZEB1 transcription factor promotes immune escape in melanomaMaud Plaschka, Valentin Benboubker, Maxime Grimont, et al.Pageof 11